SCINAI IMMUNOTHERAPEUTICS LTD. Principal Transactions Revenue, Net
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Principal Transactions Revenue, Net of EUR 24.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PrincipalTransactionsRevenue · last filed 2026-04-01
EUR
| Period end | Principal Transactions Revenue, Net | Principal Transactions Revenue, Net 12 month |
|---|---|---|
| 2025-12-31 | 24.00K EUR 20-F · filed 2026-04-01 | |
| 2024-12-31 | 24.00K EUR 20-F · filed 2025-05-07 | |
| 2024-08-21 | 26.60M EUR 20-F · filed 2026-04-01 | |
| 2023-12-31 | 24.00M EUR 20-F · filed 2024-05-15 |
USD
| Period end | Principal Transactions Revenue, Net | Principal Transactions Revenue, Net 12 month |
|---|---|---|
| 2025-12-31 | $25.60M 20-F · filed 2026-04-01 | |
| 2024-12-31 | $25.60M 20-F · filed 2025-05-07 | |
| 2024-08-21 | $29.00M 20-F · filed 2026-04-01 | |
| 2023-12-31 | $25.60M 20-F · filed 2024-05-15 |